Back to selection
60033-01 - Lecture: Special Topics in Drug Discovery and Development (2 CP)
| Semester | fall semester 2026 |
| Course frequency | Every fall sem. |
| Lecturers |
Tobias Junt (tobias.junt@unibas.ch)
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch) Alex Odermatt (alex.odermatt@unibas.ch) Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, Assessor) |
| Content | Disease-based molecular knowledge as prerequisite for identifying novel medications in preclinical and clinical settings (cf lecture content on ADAM, Special Topics DDD) Start-ups, big pharma and academic research as drivers of innovative drug-based therapies AI as potential game-changer in pharmaceutical sciences Natural compounds as starting points for efficacious therapies Peptidic drugs as highly potent endocrine modulators Digital platforms and novel analytical procedures enhancing the potential of biomarkers Antifungal approaches and their limiting adverse effects New developments e.g. in the treatment of Alzheimer's Role of drug agencies in drug development |
| Learning objectives | Learn from current drug research activities in start-ups, big pharma and academic research |
| Bibliography | For details and literature see ADAM |
| Comments | 100% attendance is compulsory. |
| Weblink | Department of Pharmaceutical Sciences |
| Admission requirements | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
| Course application | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch 100% attendance is compulsory. |
| Language of instruction | English |
| Use of digital media | No specific media used |
| Interval | Weekday | Time | Room |
|---|---|---|---|
| wöchentlich | Monday | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Dates
| Date | Time | Room |
|---|---|---|
| Monday 14.09.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 21.09.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 28.09.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 05.10.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 12.10.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 19.10.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 26.10.2026 | 10.15-12.00 | Lecture break: examination week |
| Monday 02.11.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 09.11.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 16.11.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 23.11.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 30.11.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 07.12.2026 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
| Monday 14.12.2026 | 10.15-12.00 | Lecture break: examination week |
| Modules |
Doctorate Pharmaceutical Sciences: Recommendations (PhD subject: Pharmaceutical Sciences) Doctorate Toxicology: Recommendations (PhD subject: Toxicology) Electives Master Science in Pharmacy: Recommendations (Master's Studies: Pharmacy) Module Specialisation: Medical Nanosciences (Master's Studies: Nanosciences) Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences) |
| Assessment format | continuous assessment |
| Assessment details | 100% attendance is compulsory and presentations by all students. More details will be communicated during the first lecture. |
| Assessment registration/deregistration | Reg.: course registration, dereg: cancel course registration |
| Repeat examination | no repeat examination |
| Scale | Pass / Fail |
| Repeated registration | as often as necessary |
| Responsible faculty | Faculty of Science, studiendekanat-philnat@unibas.ch |
| Offered by | Departement Pharmazeutische Wissenschaften |